MarketInOut Stock Screener Log In | Sign Up
 

Pfizer Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 06/18/2026
Pfizer Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization148,186 mln
Float5,692 mln
Earnings Date08/04/2026

EPS

1.31
Moderate

P / E

19.24
Moderately valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.36
Borderline

1-Year Forecast

29.19
Attractive

Relative Strength

27 / 100
Underperforming

Business Description

Pfizer is one of the world's largest pharmaceutical companies, researching, producing, and selling a wide range of medicines and vaccines across the United States and globally. Its portfolio spans treatments for heart disease, migraines, cancer, rare genetic conditions, infections, and immune disorders, along with preventive vaccines for diseases such as COVID-19 and meningitis. The company also sells biosimilar medicines and works alongside several major partners to develop new therapies, including cutting-edge AI-driven tools for drug discovery. Founded in 1849 and based in New York City, Pfizer remains one of the most recognized names in healthcare worldwide.

Key Fundamentals

EPS1.31
P/E19.24
ROE8.35
RPS11.07
ROIC7.75
ROA3.61
Interest Cover5.78
EBITDA, mln17,178
EV / EBITDA11.53
EV / EBIT18.70
Revenue, mln63,314
EV / Revenue3.13

Financial Strength

Altman Z-Score2.07
Piotroski F-Score 6 / 9
Beneish M-Score-2.36
Price to Intrinsic Value0.69
1-Year Target Price29.19
Shiller PE Ratio9.16
Short Ratio4.57
Short % of Float2.85

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.67% 14 / 100   
1 Month -1.75% 23 / 100   
2 Months -4.62% 19 / 100   
6 Months 2.06% 36 / 100   
1 Year 12.39% 44 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us